NCT05898802

Effect of Kimchi Intake on Body Fat in Overweight Subjects

Completed NA Last updated 10 July 2025

What this trial tests

NA trial testing Kimchi in Obesity in 90 participants. Completed in 9 November 2023.

Timeline

21 July 2023

Primary endpoint
9 November 2023

9 November 2023

Quick facts

Lead sponsor	World Institute of Kimchi
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	90
Start date	21 July 2023
Primary completion	9 November 2023
Estimated completion	9 November 2023
Sites	1 location across South Korea

Drugs / interventions tested

• Kimchi
• Placebo

Conditions studied

• Obesity — all drugs for Obesity →

Sponsor

World Institute of Kimchi

Who can join

Adults 20 to 65, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Kimchi, a traditional Korean food, is prepared through the fermentation of various ingredients. It has been reported that kimchi contains beneficial nutrients from its raw materials, as well as lactic acid bacteria (LAB) and their byproducts produced during fermentation. LAB play an important role in the fermentation process, during which the dominant LAB species emerge and undergo a transition process. Depending on the species and strain of LAB, it has specific functions such as promoting weight loss, reducing inflammation, and lowering cholesterol levels. In this study, the effects of kimchi produced from traditional recipe or kimchi fermented with lactic acid bacteria, which have anti-obesity effects, on body composition changes and metabolic disease index will be investigated in subjects with a BMI of between 23\~30kg / m2.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Single-cell RNA sequencing reveals that kimchi dietary intervention modulates human antigen-presenting and CD4⁺ T cells.
   Lee W, Moon HR, Choi H, Lee HJ, et al · · 2025 · PMID 41249184 · DOI 10.1038/s41538-025-00593-7